HUP0100292A2 - Új uretánok, tio- és ditio-analógjaik, sóik, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra - Google Patents

Új uretánok, tio- és ditio-analógjaik, sóik, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra

Info

Publication number
HUP0100292A2
HUP0100292A2 HU0100292A HUP0100292A HUP0100292A2 HU P0100292 A2 HUP0100292 A2 HU P0100292A2 HU 0100292 A HU0100292 A HU 0100292A HU P0100292 A HUP0100292 A HU P0100292A HU P0100292 A2 HUP0100292 A2 HU P0100292A2
Authority
HU
Hungary
Prior art keywords
group
alkyl
chemical bond
nitrogen
alkenyl
Prior art date
Application number
HU0100292A
Other languages
English (en)
Inventor
Gebhard Adelgoss
Bernhard Eisele
Rudolf Hurnaus
Roland Maier
Michael Mark
Peter Müller
Gebhard Schilcher
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of HUP0100292A2 publication Critical patent/HUP0100292A2/hu
Publication of HUP0100292A3 publication Critical patent/HUP0100292A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/04Drugs for disorders of the urinary system for urolithiasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02Monothiocarbamic acids; Derivatives thereof
    • C07C333/06Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14Dithiocarbamic acids; Derivatives thereof
    • C07C333/18Esters of dithiocarbamic acids
    • C07C333/24Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

A találmány tárgyát az általános képletű új uretánok, tio- és ditio-analógjaik - ahol m 0 vagy l; n 1 vagy 2; A kémiai kötés, alkilén-,alkenilén- vagy alkiniléncsoport, ahol a telítetlen csoport nemközvetlenül az Y csoporthoz kapcsolódik; X O vagy S; Y O vagy S; R1alkil-, alkenil- vagy alkinilcsoport, ahol a többszörös kémiai kötés anitrogén-szén-kötéstől el van szigetelve; R2 H, alkilcsoport, amelyetegy OH vagy alkoxicsoport szubsztituálhat, alkenil- vagyalkinilcsoport, ahol egy OH és alkoxi-szubsztituens 1-től eltérőhelyzetben kapcsolódik, és a többszörös kémiai kötés a nitrogén-szén-kötéstől el van szigetelve; vagy R1 és R2 a közöttük levőnitrogénatommal együtt egy olyan 5-7 tagú telített heterociklusosgyűrűt képez, amelyben egy, a nitrogénatommal nem szomszédosmetiléncsoportot egy O vagy S, egy -NH-vagy -N(alkil)- képletű csoporthelyettesíthet; R3 - R6 egymástól függetlenül H vagy alkilcsoport; R7alkil-, alkenil- vagy alkinilcsoport, ahol a többszörös kémiai kötés anitrogén-szén-kötéstől el van szigetelve; R8 cikloalkil-, adottesetben szubsztituált fenil- vagy naftilcsoport, vagy ha A nemtelített kémiai kötés, úgy H is - fiziológiailag elfogadható szervesvagy szervetlen savakkal képzett sóik, eljárás előállításukra és azezeket a vegyületeket hatóanyagként tartalmazó, a koleszterinbioszintézist gátló gyógyszerkészítmények képezik. Ó
HU0100292A 1997-12-10 1998-12-08 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof HUP0100292A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754795A DE19754795A1 (de) 1997-12-10 1997-12-10 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
PCT/EP1998/007962 WO1999029662A2 (de) 1997-12-10 1998-12-08 Urethane, ihre thio- und dithioanaloga, deren salze, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
HUP0100292A2 true HUP0100292A2 (hu) 2001-07-30
HUP0100292A3 HUP0100292A3 (en) 2002-11-28

Family

ID=7851380

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100292A HUP0100292A3 (en) 1997-12-10 1998-12-08 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof

Country Status (30)

Country Link
US (1) US6346545B1 (hu)
EP (1) EP1045832B1 (hu)
JP (1) JP4001317B2 (hu)
KR (1) KR20010024708A (hu)
CN (1) CN1281431A (hu)
AR (1) AR014405A1 (hu)
AT (1) ATE291570T1 (hu)
AU (1) AU747173B2 (hu)
BG (1) BG104501A (hu)
BR (1) BR9813545A (hu)
CA (1) CA2310055C (hu)
CO (1) CO5290251A1 (hu)
CZ (1) CZ20002150A3 (hu)
DE (2) DE19754795A1 (hu)
EA (1) EA003298B1 (hu)
EE (1) EE200000340A (hu)
HR (1) HRP980621A2 (hu)
HU (1) HUP0100292A3 (hu)
ID (1) ID21432A (hu)
IL (1) IL135737A0 (hu)
NO (1) NO20002968L (hu)
NZ (1) NZ505594A (hu)
PE (1) PE133599A1 (hu)
PL (1) PL341654A1 (hu)
SK (1) SK8602000A3 (hu)
TR (1) TR200001636T2 (hu)
UY (1) UY25288A1 (hu)
WO (1) WO1999029662A2 (hu)
YU (1) YU35500A (hu)
ZA (1) ZA9811263B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2715310A1 (en) * 2008-02-22 2009-08-27 Basf Se Fungicidal compositions comprising 3'-bromine-2,3,4,6'-tetramethoxy-2'-6-dimethylbenzophenone
EP2658544A4 (en) * 2010-12-27 2014-05-28 Univ Missouri OXIDOSQUALENZYCASE AS A PROTEINT ARGET FOR ANTICIPATED THERAPEUTICS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
US5011859A (en) * 1990-03-30 1991-04-30 Merrell Dow Pharmaceuticals Inc. Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
CA2047375C (en) * 1990-07-25 2003-04-15 Charlotte L. Barney Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
US5466687A (en) 1992-10-22 1995-11-14 Dr. Karl Thomae Gmbh Arylidene-1-azacycloalkanes and arylalkyl-1-azacyclo-alkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
DE4303840A1 (de) * 1992-10-22 1994-08-11 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239150A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239151A1 (de) 1992-11-20 1994-05-26 Thomae Gmbh Dr K N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4438020A1 (de) * 1994-10-25 1996-05-02 Thomae Gmbh Dr K N-substituierte Arylcyclohexylacylamine, ihre Salze mit physiologisch verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
IL135737A0 (en) 2001-05-20
PL341654A1 (en) 2001-04-23
ZA9811263B (en) 2000-06-09
CN1281431A (zh) 2001-01-24
WO1999029662A3 (de) 1999-08-19
NO20002968L (no) 2000-08-09
JP4001317B2 (ja) 2007-10-31
EE200000340A (et) 2001-08-15
HRP980621A2 (en) 1999-08-31
JP2001525393A (ja) 2001-12-11
DE59812686D1 (de) 2005-04-28
TR200001636T2 (tr) 2001-08-21
EP1045832A2 (de) 2000-10-25
CA2310055A1 (en) 1999-06-17
HUP0100292A3 (en) 2002-11-28
ID21432A (id) 1999-06-10
EA003298B1 (ru) 2003-04-24
US6346545B1 (en) 2002-02-12
ATE291570T1 (de) 2005-04-15
CA2310055C (en) 2008-09-23
YU35500A (sh) 2002-09-19
AU1759399A (en) 1999-06-28
AR014405A1 (es) 2001-02-28
WO1999029662A2 (de) 1999-06-17
CZ20002150A3 (cs) 2001-11-14
EP1045832B1 (de) 2005-03-23
NZ505594A (en) 2001-11-30
CO5290251A1 (es) 2003-06-27
AU747173B2 (en) 2002-05-09
PE133599A1 (es) 2000-01-13
BG104501A (bg) 2001-03-30
EA200000633A1 (ru) 2000-12-25
BR9813545A (pt) 2000-10-10
UY25288A1 (es) 2000-12-29
DE19754795A1 (de) 1999-06-17
SK8602000A3 (en) 2000-11-07
US20020019536A1 (en) 2002-02-14
NO20002968D0 (no) 2000-06-09
KR20010024708A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
ATE160341T1 (de) Benzolsulfonamid-derivate und verfahren zur herstellung
IL99926A0 (en) Cyclo imino derivatives,their preparation and pharmaceutical compositions containing them
HUP0100280A2 (hu) Pirrolo-, tieno-, furano- és pirazolo [3,4d] piridazonok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények
HUP0204246A2 (hu) Új tiazolo[4,5-d]pirimidin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU7503087A (en) Amide derivatives
IL109615A (en) Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
ATE146473T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
KR970015577A (ko) 아졸 유도체, 그의 사용, 제조 및 용법
ATE141606T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung
HUP0004731A2 (hu) 2-Aril-benzo[b]tiofének alkalmazása ösztrogén elvonási szindróma kezelésére alkalmas gyógyszerkészítmények előállítására
ATE81655T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
HUP0401018A2 (hu) 2H-1-benzopirán-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
ATE89739T1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
ATE144530T1 (de) Glutathionderivat
HUP0100292A2 (hu) Új uretánok, tio- és ditio-analógjaik, sóik, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
HUP0100335A2 (hu) Aza-cikloalkánokból származtatható uretánok, tio- és ditio-analógjaik, sóik, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
DE3480839D1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
HUP0202647A2 (hu) Új arilalkanoilszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DK0420224T3 (da) Anthihepatopatisk middel
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
DE69021525D1 (de) Pyrrolaldehydderivate.